Bayer completes acquisition of Perfuse Therapeutics
The following materials are not directed at or to be accessed by persons located in the United
…
AskBio’s Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Berlin, Germany, and Durham, N.C., USA, April 20, 2026 – AskBio Inc. (AskBio), a gene therapy company wholly owned and…
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
The following materials are not directed at or to be accessed by persons located in the United
…
Investigational PET Tracer from Bayer Met Primary Endpoints in Phase III Study
Not intended for UK Media Investigational PET tracer iodine 124 evuzamitide from Bayer met primary endpoints in Phase…
Bayer to acquire Perfuse Therapeutics to complement ophthalmology pipeline
Berlin, Germany and San Francisco, California USA, May 6, 2026 – Bayer and Perfuse Therapeutics Inc. today announced…